Please provide your email address to receive an email when new articles are posted on . Among implantable cardioverter defibrillators with remote monitoring systems, there are significant differences ...

BERLIN, Germany – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the publication of the IN-TIME study results in the medical journal The Lancet today. 1 The ...

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...

Please provide your email address to receive an email when new articles are posted on . Direct-acting oral anticoagulation through pacemakers or implantable cardioverter defibrillators was feasible ...

Results from the EVATEL (EVAluation of TELe follow-up) trial are the first in Europe to demonstrate potential safety and efficacy benefits from the remote follow-up of ICD patients. The trial was ...

Patients with an implantable cardioverter-defibrillator (ICD) require follow-up to monitor their clinical status and device function. Remote home monitoring has the potential to reduce costs and ...

Dr Melissa Walton-Shirley brings a personal and practice-focused perspective to headlines, research, and overlooked cardiology gems.

The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...

Digital health and telehealth have been around for some time, but it’s only with the COVID-19 pandemic that their adoption has made a big leap forward. Used at the beginning of the pandemic mainly in ...